Niacin, Memory And The 35 mg Ceiling

By MemoHoney Team · Last updated October 29, 2026 · 9 min read · Ingredient deep dive · Medical review by Dr. Aimee Duffy, MD

Niacin is the only ingredient on this label with a deficiency disease behind it, and that disease includes a dementia which reverses when the vitamin is replaced. It is also the only ingredient a capsule can carry at a studied amount. Both of those facts are real, and the distance between them is where most of the marketing in this category lives.

What niacin is and what it becomes

Niacin is vitamin B3, and it comes in two forms that behave differently: nicotinic acid and nicotinamide. Both are converted into nicotinamide adenine dinucleotide, universally called NAD, which is one of the busiest molecules in the body.

NAD is the electron carrier that lets a cell release energy from food. Hundreds of reactions use it, and the brain, which burns roughly a fifth of the body's energy while weighing a fiftieth of it, is among the tissues most dependent on that process working.

So the biological link between this vitamin and thinking is not a marketing invention. It is a real dependency, set out plainly in the reference materials any dietitian would use (the NIH Office of Dietary Supplements niacin fact sheet). What is in dispute is what follows from it.

A label reading only 'Niacin (Vitamin B3)' does not say which of these it is, which matters mainly to anyone who flushes.

The deficiency disease, and what it proves

Severe niacin deficiency causes pellagra, remembered by generations of medical students as the four Ds: dermatitis, diarrhoea, dementia and death. The third of those is the one that matters here. Advanced deficiency produces confusion, memory impairment and disorientation, and replacing the vitamin reverses it.

That is about as clean a demonstration as nutrition offers that this particular vitamin is necessary for the brain to work. It is a genuine, documented, causal link.

What it is not is an argument for supplementation in somebody who eats normally. Pellagra in the developed world today is largely confined to specific circumstances: severe alcohol dependence, certain malabsorption states, a few rare metabolic conditions. The jump from 'deficiency causes cognitive symptoms' to 'extra improves cognition' is the jump this whole shelf keeps making, and it is not supported by the deficiency evidence.

The cognition evidence, and what kind it is

There is real evidence linking niacin intake to cognition in ordinary people, and it is repays a careful reading, because in this field the KIND of study behind a result decides most of what the result is worth.

The Chicago Health and Aging Project followed a large community sample of older adults and reported fewer incident cases of Alzheimer's disease among those whose diets carried Alzheimer's disease and with slower cognitive decline over roughly six years (the Chicago Health and Aging Project analysis). Separately, the CARDIA study followed intake of niacin, folate, B6 and B12 from young adulthood into midlife and related it to cognitive function later (the CARDIA midlife cognition study).

Both are observational, which sets a hard ceiling on what they can show. They record diets and then record outcomes; but a person whose diet is rich in niacin is rarely unlike a person whose diet is poor in it in only that one respect. Income, schooling, the rest of the plate, exercise and tobacco all travel with it, and adjusting for them narrows the gap without closing it.

The strongest trial-level evidence anywhere near this territory is not about niacin alone. COSMOS-Mind randomised older adults to a daily multivitamin or placebo for three years and found a modest benefit on global cognition (the COSMOS-Mind trial). That is a randomised finding, it is real, and it is for a cheap and unglamorous product rather than for any single vitamin.

The 35 mg ceiling and the flush

An adult needs fourteen to sixteen milligrams of niacin equivalents a day. The tolerable upper intake level for the added form — the niacin in supplements and fortified foods, as distinct from what occurs naturally in food — is thirty-five milligrams a day (the NIH Office of Dietary Supplements niacin fact sheet).

That upper level is set on the flush rather than on anything dangerous. Nicotinic acid triggers prostaglandin release in the skin, which dilates the small vessels near the surface and produces a warm reddening across the face, neck and chest, typically starting within half an hour and lasting up to an hour (a 2024 review of the niacin flush). It is harmless, it is uncomfortable, and it is what an upper intake level of thirty-five milligrams is protecting you from.

For a supplement buyer that ceiling is genuinely useful. It means a manufacturer selling a daily product in the United States has a strong commercial reason to stay under it, which in turn means a capsule's niacin content is very likely to be somewhere in a range a buyer can reason about, even when the label prints no figure.

That is a rare situation on this shelf and it is worth dwelling on for a moment. For every other ingredient in a capsule of this kind, the absence of a number leaves a reader with an unbounded unknown: the amount could be anything from a token sprinkle upward, and nothing external constrains it. For niacin there is a regulatory ceiling that a commercially sensible manufacturer will respect, and an adult requirement well below it. The plausible range is therefore narrow, which is the only place on this label where a missing figure matters less than it looks.

• Adult requirement: 14–16 mg a day of niacin equivalents.
• Upper intake level for added niacin: 35 mg a day.
• Flushing typically begins somewhere around 30–50 mg of nicotinic acid.
• Nicotinamide does not flush and has a higher tolerance.
• A flush from a supplement is a sign of the form and the amount, not of a fault.

Where niacin genuinely becomes a problem

Niacin has a reputation for harm and that reputation was earned at doses nobody sells as a supplement. As a lipid-modifying medicine it was given at one to two grams a day, forty to sixty times the supplemental upper intake level.

At that level the harms are documented and serious. The HPS2-THRIVE trial of extended-release niacin with laropiprant recorded significant excesses of bleeding, infection and disturbances of glucose control (the HPS2-THRIVE safety analysis). That trial is part of why niacin largely disappeared from cardiovascular practice.

The distance between 35 mg and 2,000 mg is the whole of the argument, and conflating the two is a common error in both directions: people either dismiss a vitamin because of what a medicine did, or assume a medicine's dose is available in a capsule. Neither is right.

1. A supplemental amount sits at or under 35 mg a day of the added form.
2. A pharmacological amount is 1,000 to 2,000 mg a day and is a prescribing decision.
3. The harms in the large trials belong to the second category.
4. The flush belongs to both, which is why it is the most commonly misread signal.

The mistake people make with two products

Here is the practical risk, and it has nothing to do with any single product being badly made. Niacin appears in a great many things at once: multivitamins, B-complexes, energy drinks, fortified cereals and a good proportion of the memory and focus shelf.

Somebody taking a B-complex in the morning and a memory capsule with it may be well past thirty-five milligrams of added niacin without ever seeing a figure that looks large. The first sign is usually a flush, which people then attribute to the newer product rather than to the total.

The fix is dull and effective: add up the added niacin across everything you take. If a label prints no figure, as this one does not, treat it as an unknown that could be anywhere below the ceiling and drop something else if you flush. That advice, and the rest of the interaction list, is on the side effects page.

References